ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Infectious Disease

Top Infectious Disease Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NICOLAS DELAPENA M.D.

Infectious Disease

22,328

$1.33M

717
520 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 43%

$60
Average prescription price

Avg: $300

NEIL FLYNN MD, MPH

Infectious Disease

13,500

$4.59M

235
19 are 65+

33%
patients receiving schedule two controlled substances

Avg: 3%

52%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 43%

$340
Average prescription price

Avg: $300

ANTONIO BALATBAT M. D.

Infectious Disease

12,716

$797K

472
336 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 43%

$63
Average prescription price

Avg: $300

MARCIA SENTENO MD

Infectious Disease

11,236

$4.67M

306
27 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 43%

$416
Average prescription price

Avg: $300

ARDIS MOE MD

Infectious Disease

11,215

$3.94M

195
21 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

44%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 43%

$351
Average prescription price

Avg: $300

FRANCO FELIZARTA MD

Infectious Disease

10,371

$2.89M

289
78 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 43%

$279
Average prescription price

Avg: $300

SHAWN HASSLER M.D.

Infectious Disease

10,265

$4.31M

200
41 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

49%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 43%

$420
Average prescription price

Avg: $300

DIANNE MARTIN MD

Infectious Disease

7,954

$540K

297
260 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 43%

$68
Average prescription price

Avg: $300

SHAHE KOMSHIAN M.D.

Infectious Disease

7,317

$356K

363
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 43%

$49
Average prescription price

Avg: $300

SUSAN SANCHEZ M.D.

Infectious Disease

6,966

$2.49M

139
18 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

50%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 43%

$357
Average prescription price

Avg: $300

STEVEN LARSON MD

Infectious Disease

6,890

$1.11M

291
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 43%

$161
Average prescription price

Avg: $300

MARC LARIVIERE MD

Infectious Disease

6,762

$3.56M

168
71 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

45%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 43%

$527
Average prescription price

Avg: $300

ANTHONY MILANES M.D.

Infectious Disease

6,533

$309K

325
299 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 43%

$47
Average prescription price

Avg: $300

HON YU MD

Infectious Disease

6,330

$488K

178
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 43%

$77
Average prescription price

Avg: $300

MICHAEL NAKATA MD

Infectious Disease

6,199

$499K

390
362 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 43%

$80
Average prescription price

Avg: $300

ANTONIO ESCOBEDO MD

Infectious Disease

5,984

$2.48M

162
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 43%

$414
Average prescription price

Avg: $300

THOMAS DEETZ M.D.

Infectious Disease

5,910

$855K

317
252 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 43%

$145
Average prescription price

Avg: $300

MICHAEL SOMERO M.D.

Infectious Disease

5,766

$3.33M

271
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 43%

$578
Average prescription price

Avg: $300

CATHERINE DIAMOND MD

Infectious Disease

5,710

$2.45M

112
15 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 43%

$429
Average prescription price

Avg: $300

RICHARD POLLARD MD

Infectious Disease

5,703

$2.03M

185
15 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

46%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 43%

$355
Average prescription price

Avg: $300

SHUBHA KERKAR MD

Infectious Disease

5,552

$3.33M

192
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 43%

$601
Average prescription price

Avg: $300

EDWARD BROOKS MD

Infectious Disease

5,500

$1.95M

138
13 are 65+

21%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 43%

$355
Average prescription price

Avg: $300

MATTEO DINOLFO MD

Infectious Disease

5,377

$270K

276
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 43%

$50
Average prescription price

Avg: $300

ELIZABETH KAILATH MD,MPH

Infectious Disease

5,306

$297K

238
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 43%

$56
Average prescription price

Avg: $300

PAOLO TROIA-CANCIO M.D.

Infectious Disease

5,156

$1.86M

114
12 are 65+

28%
patients receiving schedule two controlled substances

Avg: 3%

44%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 43%

$361
Average prescription price

Avg: $300

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank